Okmetic Oyj - Changes board/management/auditors

KAI SEIKKU APPOINTED NEW PRESIDENT OF OKMETIC, NEW INCENTIVE PLAN FOR THE TOP MANAGEMENT OF OKMETIC OYJ IN THE FORM OF A SHARE OWNERSHIP PROGRAM

OKMETIC OYJ      STOCK EXCHANGE RELEASE     25 JANUARY 2010   AT 11.00 A.M

KAI SEIKKU APPOINTED NEW PRESIDENT OF OKMETIC, NEW INCENTIVE PLAN FOR THE TOP
MANAGEMENT OF OKMETIC OYJ IN THE FORM OF A SHARE OWNERSHIP PROGRAM

The Board of Directors of Okmetic Oyj has today appointed M.Sc. (Econ.) Kai
Seikku the new President of the Company. Seikku will start in his position today
on 25 January 2010.

Kai Seikku (born 1965) has previously served as CEO of HKScan Corporation and
before that, among others, as CEO for Hasan & Partners Oy. He has also been
employed for The Boston Consulting Group.

The Chairman of the Board of Directors, Henri Österlund, comments: "Kai Seikku
has a strong record of leading change and he is an experienced leader in expert
organizations. We expect Kai's competence to significantly contribute to
Okmetic's development in a situation, where it is possible to combine the
Company's world class expertise and the potential offered by the growing
markets. In addition, the significant commitment by Kai Seikku and the deputy to
the President of the Company Mikko Montonen through their own investments is
very welcome".

The Board of Directors of Okmetic Oyj (Okmetic) has today decided on a new share
ownership program directed to the top management of Okmetic Group. The purpose
of the program is to commit the Company's top management by encouraging them to
acquire and hold the Company's shares and thus to increase Okmetic's shareholder
value in the long term.

For purposes of the share ownership, the Company's President Kai Seikku and
deputy to the President Mikko Montonen are establishing a limited company, the
entire share capital of which they own. The purpose of such company is to
acquire Okmetic shares by subscribing for new Okmetic shares in a share issue
directed to the company. The acquisitions are financed on one hand by capital
investments in the company to be established by the management, in the maximum
total amount of EUR 400,000, and on the other hand by a loan to be granted by
Okmetic. Other key persons in the Company may later be made shareholders of the
company.

On the basis of the authorization granted by the Annual General Meeting of
Shareholders of Okmetic on 2 April 2009, the Board of Directors of Okmetic
decided today on a share issue against payment, which was directed to the
company to be established owned by the top management. A total of 400,000 new
shares in Okmetic was in the share issue offered for subscription to the company
to be established in derogation from the shareholders' pre-emptive subscription
right. There are from Okmetic's point of view weighty financial reasons for the
derogation from the shareholders' pre-emptive subscription right, as the shares
issued in the share issue will be used for the incentive and commitment
arrangement for the management.

The subscription price of the new share of Okmetic is EUR 3/share. The
subscription price is based on the prevailing market price of the share and the
size of the share issue.

The company to be established has today subscribed for all the shares offered
and undertaken to pay the subscription price by February 26 2010. The Board of
Directors has approved the subscription of the shares. As a consequence of the
share subscriptions, Seikku and Montonen hold approximately 2.3 % of the Okmetic
shares through the company established by them.

The amount that corresponds to the subscription price of the new shares, EUR
1,200,000, will be credited to the reserve for invested unrestricted equity of
the Company. The right to dividend and other shareholder rights will commence
when the new shares have been entered into the Trade Register and the Company's
shareholders' register. The shares will be registered on the book-entry account
of the subscriber and applied for public trading on the NASDAQ OMX Helsinki Ltd.
when the shares will have been entered into the Trade Register, on or about week
9.

As a result of the share issue, the number of Okmetic's shares increases from
the current 16,887,500 to 17,287,500 shares. The share capital will not change
as a consequence of the share issue. The shares subscribed for in the share
issue represent approximately 2.3 % of the shares and votes in Okmetic after the
completion of the share issue.

The program will be in force approximately 3 years, at which time it is intended
to be dissolved in a manner to be determined later. The program may be
dissolved, e.g. by placing the company to be established into liquidation or by
merging it into Okmetic, or by otherwise selling the Okmetic shares held by the
company to be established. The program will be extended by one year, in case the
trading price of Okmetic's share during the five trading days following the
original expiry date of the program is lower than the share subscription price,
for which the company to be established has acquired its Okmetic shares.

As part of the arrangement, the Board of Directors of Okmetic has on 25 January
2010 decided to grant to the company to be established an interest-bearing loan
in the maximum amount of EUR 8,000,000 for purposes of financing the
subscription of the Okmetic shares. The entire loan will be repaid at the
expiration of the program, at the latest. Should the program be extended by one
year, the loan period may be extended respectively. The company to be
established has a right to repay the loan prematurely at any time. The Board of
Directors of Okmetic has also granted a loan to Montonen to be used in the
capitalization of the company to be established.

During the term of the program, the transfer of the Okmetic shares held by the
company to be established has been restricted and the shares of said company may
not be transferred before the expiry of the program.

OKMETIC OYJ

The Board of Directors

For further information, please contact:

The Chairman of the Board of Directors, Henri Österlund, Okmetic Oyj,
tel. +358 50 348 9600

Distribution:

NASDAQ OMX Helsinki
Principal media
www.okmetic.com

OKMETIC IN BRIEF

Take it higher

Okmetic is a technology company which supplies tailor-made silicon wafers for
sensor and semiconductor industries and sells its technological expertise to the
solar cell industry. Okmetic provides its customers with solutions that boost
their competitiveness and profitability.

Okmetic's silicon wafers are part of a further processing chain that produces
end products that improve human interaction and quality of life. Okmetic's
products are based on high-tech expertise that generates added value for
customers, innovative product development and an extremely efficient production
process.

Okmetic has a global customer base and sales network, production plants in
Finland and the US and contract manufacturers in Japan and China.

Okmetic's shares are listed on NASDAQ OMX Helsinki under the code OKM1V. For
more information on the company, please visit our website at www.okmetic.com.





[HUG#1376642]

Attachments:

OKME0210.pdf